Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Agilon Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053355
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Expenses: | ||||
| Medical services expense | 1,296,235 | 1,445,245 | 2,565,863 | 2,847,112 |
| Other medical expenses | 91,369 | 2,164 | 177,186 | 82,357 |
| General and administrative | 88,505 | 56,281 | 142,736 | 122,237 |
| Depreciation and amortization | 6,864 | 7,319 | 13,651 | 14,195 |
| Total expenses | 1,482,973 | 1,511,009 | 2,899,436 | 3,065,901 |
| Income (loss) from operations | 11,770 | (116,027) | 15,767 | (138,137) |
| Other income (expense): |
Item 1. Financial Statements
FAQ
- What is Agilon Health's G&A?
- Agilon Health (AGL) reported G&A of $88.51M in Q2 2026.
- How has Agilon Health's G&A changed year-over-year?
- Agilon Health's G&A increased by 57.3% year-over-year, from $56.28M to $88.51M.
- What is the long-term trend for Agilon Health's G&A?
- Over 4 years (2021 to 2025), Agilon Health's G&A has grown at a -13.6% compound annual growth rate (CAGR), from $427.5M to $238.54M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Agilon Health's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude